What we have learned from risk charts?

被引：1

作者：

Arslan, Eren ^{[1
]}

Erdine, Serap ^{[1
]}

机构：

[1] Istanbul Univ Cerrahpasa, Med Fac, Internal Med Dept, TR-34452 Istanbul, Turkey

来源：

FUTURE CARDIOLOGY | 2010年 / 6卷 / 03期

关键词：

D O I：

10.2217/FCA.10.16

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Risk factor assessment is an important issue in preventing and treating cardiovascular diseases. Three widely used risk charts: the Framingham, Systemic Coronary Risk Evaluation and the European Society of Hypertension/European Society of Cardiology charts, are discussed, and a recent study by Sehestedt et al. comparing systemic coronary risk evaluation and the European Society of Hypertension/European Society of Cardiology chart, is also evaluated in this article.

引用

页码：285 / 287

页数：3

共 14 条

[11] Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population [J].

Sehestedt, Thomas ;

Jeppesen, Jorgen ;

Hansen, Tine W. ;

Rasmussen, Susanne ;

Wachtell, Kristian ;

Ibsen, Hans ;

Torp-Pedersen, Christian ;

Olsen, Michael H. .

JOURNAL OF HYPERTENSION, 2009, 27 (12) :2351-2357

[12] Cardiovascular mortality in hypertensive men according to presence of associated risk factors [J].

Thomas, F ;

Rudnichi, A ;

Bacri, AM ;

Bean, K ;

Guize, L ;

Benetos, A .

HYPERTENSION, 2001, 37 (05) :1256-1261

[13] Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography [J].

Viazzi, F ;

Parodi, D ;

Leoncini, G ;

Vettoretti, S ;

Ratto, E ;

Vaccaro, V ;

Ravera, M ;

Tomolillo, C ;

Bezante, GP ;

Del Sette, M ;

Deferrari, G ;

Pontremoli, R .

JOURNAL OF HYPERTENSION, 2004, 22 (05) :907-913

[14] When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal [J].

Zanchetti, Alberto ;

Grassi, Guido ;

Mancia, Giuseppe .

JOURNAL OF HYPERTENSION, 2009, 27 (05) :923-934

← 1 2 →